Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-03-10 @ 11:45 PM
Study NCT ID:
NCT06482268
Status:
RECRUITING
Last Update Posted:
2025-01-29
First Post:
2024-06-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Sponsor:
University of California, San Diego
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | PD - Parkinson's Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Parkinson's Disease | View |
| None | Ataxia | View |
| None | Dopaminergic | View |
| None | Dyskinesia | View |
| None | PD | View |
| None | Neurodegenerative Disease | View |
| None | Brain Disease | View |
| None | CNS | View |
| None | Movement Disorder | View |
| None | Central Nervous System Disease | View |
| None | FDOPA | View |
| None | MRI | View |
| None | Corpus striatum | View |